IRIS
GANDOGLIA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.928
AS - Asia 131
SA - Sud America 17
NA - Nord America 11
AF - Africa 3
Totale 2.090
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.927
SG - Singapore 59
VN - Vietnam 34
CN - Cina 27
BR - Brasile 9
US - Stati Uniti d'America 9
AR - Argentina 4
HK - Hong Kong 4
ID - Indonesia 2
MX - Messico 2
PK - Pakistan 2
CO - Colombia 1
GF - Guiana Francese 1
KE - Kenya 1
KZ - Kazakistan 1
OM - Oman 1
PE - Perù 1
SA - Arabia Saudita 1
SE - Svezia 1
TN - Tunisia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.090
Salva come PNG Salva come JPEG
Città #
Genova 803
Genoa 775
Rapallo 182
Vado Ligure 136
Singapore 15
Bordighera 14
Hanoi 13
Ho Chi Minh City 11
Beijing 10
Hong Kong 4
Pisa 4
Ashburn 3
Alessandria 2
Milan 2
Seveso 2
Almaty 1
Arequipa 1
Aryanah 1
Atlanta 1
Biên Hòa 1
Can Tho 1
Coronel Vivida 1
Cotia 1
Da Nang 1
Garín 1
Haiphong 1
Iguape 1
Itajubá 1
Itaquaquecetuba 1
Jakarta 1
Jequié 1
Johannesburg 1
Juazeiro do Norte 1
Lahore 1
Lanús 1
Luziânia 1
Lấp Vò 1
Manado 1
Maturín 1
Medellín 1
Mexico City 1
Nairobi 1
New York 1
Querétaro City 1
Rawalpindi 1
Reconquista 1
Riyadh 1
Rome 1
Rémire-Montjoly 1
Seeb 1
Shenyang 1
Sorocaba 1
Stockholm 1
Thái Nguyên 1
Villa Ballester 1
Vĩnh Long 1
Vĩnh Tường 1
Vũng Tàu 1
Totale 2.019
Salva come PNG Salva come JPEG
Nome #
Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine 185
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 178
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 174
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? 165
Teriflunomide treatment reduces B cells in patients with MS. 148
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection. 145
JCV-DNA testing during natalizumab treatment is complementary to anti-JCV antibodies for PML risk stratification 127
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 111
Natural killer cells are functionally defective in multiple sclerosis 100
Human B cells express Neuron/Glial 2 antigen. Possible implications for health and autoimmune disease of the central nervous system. 99
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 95
The PRESTO study: awareness of stroke symptoms and time from onset to intervention 92
Impaired suppressor function of NK cells in multiple sclerosis 92
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 84
Impaired suppressor function of CD56bright NK cells in early multiple sclerosis 82
How can we define a brain health chart? A narrative review and a proposal 73
Penetrance of the V203I variant of the PRNP gene: report of a patient with stroke-like onset of Creutzfeld-Jacob Disease and review of published cases 69
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: who gains from it? 67
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 46
Totale 2.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.831
article - articoli 7.484
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.315
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202171 0 0 0 0 0 8 5 7 5 12 9 25
2021/2022177 6 10 11 16 11 11 9 42 16 15 10 20
2022/2023226 20 28 8 16 34 38 0 13 33 5 26 5
2023/2024183 6 17 10 25 14 21 24 17 9 8 9 23
2024/2025395 17 28 7 32 35 36 40 88 12 14 40 46
2025/2026488 105 46 85 94 136 22 0 0 0 0 0 0
Totale 2.132